Business, Health Care

Legend Biotech announces Phase 1b/2 study data of cilta-cel, an investigational BCMA CAR-T, showing early, deep, and durable responses in heavily pretreated patients with multiple myeloma

Combined Phase 1b/2 CARTITUDE-1 study presented at ASH 2020 Annual Meeting show 97 percent overall response rate and 12-month progression free survival rate of 77 percent at median follow up of 12.4 months SOMERSET, N.J.–(BUSINESS WIRE)–Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”),

Business

AM Best affirms credit ratings of Anthem, Inc. and its subsidiaries

OLDWICK, N.J.–(BUSINESS WIRE)–AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of “a+” of the core Blue Cross Blue Shield-branded insurance subsidiaries of Anthem, Inc. (Anthem) (Indianapolis, IN) [NYSE:ANTM]. Concurrently, AM

Business, Media & Communications

Semperis appoints Rob Porell as Chief Financial Officer

Proven Financial Executive to Focus on Building Financial Strategy and Infrastructure to Support the Rapid Expansion of East Coast-Based Cybersecurity Leader NEW YORK–(BUSINESS WIRE)–#accounting—Semperis, the pioneer of identity-driven cyber resilience for enterprises, today announced the appointment of Rob Porell as its CFO.